|
|
???tair.name??? >
???browser.page.title.author???
|
"wu shang gin"???jsp.browse.items-by-author.description???
Showing items 31-55 of 57 (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition
|
Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 張逸良; 楊泮池; 余忠仁; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Association of BIM Deletion Polymorphism With Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Adenocarcinoma
|
Wu, Shang-Gin; Liu, Yi-Nan; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 余忠仁; 吳尚俊; 施金元 |
| 大葉大學 |
2015-04 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.
|
Liu, Yi-Nan;Chang, Tzu-Hua;Tsai, Meng-Feng;Wu, Shang-Gin;Tsai, Tzu-Hsiu;Chen, Hsuan-Yu;Yu, Sung-Liang;Yang, James Chih-Hsin;Shih, Jin-Yuan |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2014 |
Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case
|
Gow, Chien-Hung; Wu, Shang-Gin; Chang, Yih-Leong; Shih, Jin-Yuan; 張逸良; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2014 |
Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元 |
| 國立臺灣大學 |
2014 |
Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non-Small-Cell Lung Cancer
|
Lin, Yen-Ting; Wang, Yu-Fen; Yang, James Chih-Hsin; Yu, Chong-Jen; Wu, Shang-Gin; Shih, Jin-Yuan; Yang, Pan-Chyr; 楊志新; 楊泮池; 余忠仁; 林奕廷; 吳尚俊; 施金元; 王郁棻 |
| 國立臺灣大學 |
2013 |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Wu, Shang-Gin; Hu, Fu-Chang; Chang, Yih-Leong; Lee, Yung-Chie; Yu, Chong-Jen; Chang, Yeun-Chung; Wu, Jenn-Yu; Shih, Jin-Yuan; Yang, Pan-Chyr; 張允中; 張逸良; 楊泮池; 余忠仁; 吳尚俊; 施金元; 李元麒; 巫震宇 |
| 國立臺灣大學 |
2013 |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu, Shang-Gin; Yu, Chong-Jen; Tsar, Meng-Feng; Liao, Wei-Yu; Yang, Chih-Hsin; Jan, I-Shiow; Yang, Pan-Chyr; Shin, Jin-Yuan; 楊志新; 詹一秀; 楊泮池; 廖唯昱; 余忠仁 |
| 國立臺灣大學 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu, Pei-Fang; Huang, Wen-Chang; Yang, James Chih-Hsin; Lu, Yen-Shen; Shih, Jin-Yuan; Wu, Shang-Gin; Lin, Ching-Hung; Cheng, Ann-Lii; 楊志新; 盧彥伸; 鄭安理; 吳尚俊; 施金元; 林璟宏 |
| 大葉大學 |
2012-06-15 |
Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma
|
Tsai, Tzu-Hsiu;Wu, Shang-Gin;Chang, Yih-Leong;Wu, Chen-Tu;Tsai, Meng-Feng;Wei, Pin-Fei;Yang, Chih-Hsin;Yu, Chong-Jen;Yang, Pan-Chyr;Shih, Jin-Yuan |
| 國立臺灣大學 |
2012 |
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR
|
Wu, Shang-Gin; Kuo, Yao-Wen; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 郭耀文; 吳尚俊; 施金元; 陳盈憲 |
| 國立臺灣大學 |
2012 |
Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Chang, Yih-Leong; Wu, Chen-Tu; Tsai, Meng-Feng; Wei, Pin-Fei; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 吳振都; 楊志新; 張逸良; 楊泮池; 余忠仁; 衛品妃; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2012 |
Clinical Outcomes in Non-Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR
|
Chung, Kuei-Pin; Wu, Shang-Gin; Wu, Jenn-Yu; Yang, James Chih-Hsin; Yu, Chong-Jen; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr; 楊泮池; 余忠仁; 衛品妃; 吳尚俊; 施金元; 巫震宇 |
| 大葉大學 |
2011-08-9 |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction.
|
Wu, Shang-Gin;Chang, Yih-Leong;Lin, Jou-Wei;Wu, Chen-Tu;Chen, Hsuan-Yu;Tsai, Meng-Feng;Lee, Yung-Chie;Yu, Chong-Jen;Shih, Jin-Yuan |
| 大葉大學 |
2011-08-09 |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction.
|
Wu, Shang-Gin;Chang, Yih-Leong;Lin, Jou-Wei;Wu, Chen-Tu;Chen, Hsuan-Yu;Tsai, Meng-Feng;Lee, Yung-Chie;Yu, Chong-Jen;Shih, Jin-Yuan |
| 國立臺灣大學 |
2010 |
Good Response to Gefitinib in Lung Adenocarcinoma Harboring Coexisting Eml 4-Alk Fusion Gene and Egfr Mutation
|
郭耀文; 吳尚俊; 何肇基; 施金元; KUO, YAO-WEN; WU, SHANG-GIN; HO, CHAO-CHI; SHIH, JIN-YUAN |
| 國立臺灣大學 |
2009 |
Successful Weaning after Plasma Exchange for Polyneuropathy Related to Poems Syndrome
|
吳尚俊; 郭炳宏; 楊泮池; WU, SHANG-GIN; KUO, PING-HUNG; YANG, PAN-CHYR |
| 國立臺灣大學 |
2008-10 |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.
|
Wu, Jenn-Yu; Yu, Chong-Jen; Chih-HsinYang; Wu, Shang-Gin; Chiu, Yueh-Hsia; Gow, Chien-Hung; Chang, Yeun-Chung; Hsu, Ya-Chieh; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr |
| 國立臺灣大學 |
2008 |
Lung Adenocarcinoma with Good Response to Erlotinib after Gefitinib Treatment Failure and Acquired T790m Mutation
|
吳尚俊; 施金元; 余忠仁; 楊泮池; WU, SHANG-GIN; SHIH, JIN-YUAN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2008 |
Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma
|
吳尚俊; 高劍虹; 余忠仁; 張逸良; 施金元; 李元麒; 楊泮池; WU, SHANG-GIN; GOW, CHIEN-HUNG; YU, CHONG-JEN; CHANG, YIH-LEONG; SHIH, JIN-YUAN; LEE, YUNG-CHIE; YANG, PAN-CHYR |
Showing items 31-55 of 57 (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page
|
